Abstract
Background
To explore the molecular mechanisms involved in pathophysiology of malignant and benign salivary gland tumors (SGTs), we investigated main tumor-inducing chemokines and chemokine receptors, CXCL12/CXCR4/ACKR3 (CXCR7), CXCR3/CXCL10, CCR5/CCL5, CCL21/CCR7, CCL2, CCR4, CXCR5, CCR6, and CXCL8 in tumor tissues.
Patients and methods
Parotid tissues were obtained from 30 patients with malignant and benign SGTs. Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to determine the mRNA expression pattern of the mentioned chemokines/chemokine receptors and immunohistochemistry (IHC) was performed to verify the expression of CCR7.
Results
Expression levels of CCR7 and CCR4 transcripts were higher in the tumor tissues of malignant cases in comparison to benign ones (p = 0.03 and 0.02). Immunohistochemistry analysis confirmed that the protein level of CCR7 concurred with the mRNA expression. CCL2 gene transcripts were observed with a higher expression in patients with tumor-free lymph nodes (LN–) and early stages, whereas CCR7 transcript was higher in LN+ and late stages of the disease. A significant inverse correlation was found between CXCL10 transcript and tumor size in benign cases. The mRNA expression of CCR7, CCR4, CXCR3, CCL21, CCL5, and CXCL12 was significantly higher in mucoepidermoid carcinoma in comparison to pleomorphic adenoma subtypes (p < 0.05).
Conclusion
On the basis of the present study, it was determined that malignant and benign SGTs exhibit a distinct pattern of chemokines and chemokine receptors, which are probably associated with known biological and clinical behaviors of these tumors. Significant increased CCR4 and CCR7 expression in malignant SGTs might play a central role in malignant transformation that introduces them as new targets for cancer immunotherapy.
Similar content being viewed by others
References
Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002; 8: 229–40.
Jaso J, Malhotra R. Adenoid cystic carcinoma. Arch Pathol Lab Med 2011; 135: 511–5.
Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309–22.
da Silva JM, Soave DF, Moreira Dos Santos TP, et al. Significance of chemokine and chemokine receptors in head and neck squamous cell carcinoma: a critical review. Oral Oncol 2016; 56: 8–16.
Haghshenas MR, Khademi B, Ashraf MJ, Ghaderi A, Erfani N. Helper and cytotoxic T-cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors. Oral Dis 2016; 22: 566–72.
Haghshenas MR, Khademi B, Faghih Z, Ghaderi A, Erfani N. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunol Lett 2015; 164: 109–16.
Bachelerie F, Ben-Baruch A, Burkhardt AM, et al. International Union of Basic and Clinical Pharmacology. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 2014; 66: 1–79.
Balkwill FR. The chemokine system and cancer. J Pathol 2012; 226: 148–57.
Chow MT, Luster AD. Chemokines in cancer. Cancer Immunol Res 2014; 2: 1125–31.
Lou H, Fang J, Li P, et al. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma. PLoS One 2015; 10: e0126463.
Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942–9.
Razmkhah M, Jaberipour M, Safaei A, Talei AR, Erfani N, Ghaderi A. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients. Eur Cytokine Netw 2012; 23: 72–7.
Liu FY, Safdar J, Li ZN, et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. Int J Oncol 2014; 45: 2502–10.
Ueda M, Shimada T, Goto Y, et al. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma. Auris Nasus Larynx 2010; 37: 488–95.
Liu XY, Song L, Wang Z. CCR7: A metastasis and prognosis indicator of postoperative patients with esophageal carcinoma. Hepatogastroenterology 2013; 60: 747–50.
Du P, Liu Y, Ren H, et al. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis. Gastric Cancer 2017; 20: 235–45.
Shi M, Chen D, Yang D, Liu XY. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. J Exp Clin Cancer Res 2015; 34:149.
Chen J, Cui YU, Liu L, et al. CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma. Oncol Lett 2016; 11: 735–40.
Sperveslage J, Frank S, Heneweer C, et al. 215: The role of chemokine receptor CCR7 and Its ligands CCL19 and CCL21 in tumor progression of pancreatic ductal adenocarcinoma. Cytokine 2013; 63:302.
Tsujikawa T, Yaguchi T, Ohmura G, et al. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. Int J Cancer 2013; 132: 2755–66.
Yang Y, Du L, Yang X, et al. AberrantCCR4expression is involved in tumor invasion of lymph node-negative human gastric cancer. PLoS One 2015; 10: e0120059.
Mardani M, Andisheh Tadbir A, Khademi B, Melekzadeh M, Vaziri L. Decreased serum monocyte chemoattractant protein1 in salivary gland tumor patients. Asian Pac J Cancer Prev 2016; 17: 3601–4.
Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313–26.
Suzuki S, Maeda A, Miura M, Ozeki S. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system in human salivary gland carcinoma motility. Oral Sci Int 2006; 3: 13–20.
Uchida D, Kuribayashi N, Kinouchi M, et al. Expression and function of CXCR4 in human salivary gland cancers. Clin Exp Metastasis 2013; 30: 133–42.
Shen Z, Li T, Chen D, et al. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma. Oncol Rep 2014; 31: 800–6.
Lanzel E, Robinson RA, Zimmerman MB, Pourian A, Hellstein JW. The use of immunohistochemistry in detection of perineural invasion in mucoepidermoid carcinoma. Oral Surg Oral Med OralPathol Oral Radiol 2016; 121: 636–42.
Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator? Oral Oncol 2009; 45: 936–40.
Ma B, Khazali A, Wells A. CXCR3 in carcinoma progression. Histol Histopathol 2015; 30: 781–92.
Kondo T, Ito F, Nakazawa H, Horita S, Osaka Y, Toma H. High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. J Urol 2004; 171: 2171–5.
Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (Review). Oncol Lett 2011; 2: 583–9.
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Haghshenas, M.R., Ashraf, M.J., Khademi, B. et al. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7. Eur Cytokine Netw 28, 27–35 (2017). https://doi.org/10.1684/ecn.2017.0388
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ecn.2017.0388